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Abstract
Background: Exfoliated cervical cells are used in cytology-based cancer screening and may also
be a source for molecular biomarkers indicative of neoplastic changes in the underlying tissue.
However, because of keratinization and terminal differentiation it is not clear that these cells have
an mRNA profile representative of cervical tissue, and that the profile can distinguish the lesions
targeted for early detection.
Results: We used whole genome microarrays (25,353 unique genes) to compare the transcription
profiles from seven samples of normal exfoliated cells and one cervical tissue. We detected 10,158
genes in exfoliated cells, 14,544 in the tissue and 7320 genes in both samples. For both sample types
the genes grouped into the same major gene ontology (GO) categories in the same order, with
exfoliated cells, having on average 20% fewer genes in each category. We also compared
microarray results of samples from women with cervical intraepithelial neoplasia grade 3 (CIN3, n
= 15) to those from age and race matched women without significant abnormalities (CIN1, CIN0;
n = 15). We used three microarray-adapted statistical packages to identify differential gene
expression. The six genes identified in common were two to four fold upregulated in CIN3
samples. One of these genes, the ubiquitin-conjugating enzyme E2 variant 1, participates in the
degradation of p53 through interaction with the oncogenic HPV E6 protein.
Conclusion: The findings encourage further exploration of gene expression using exfoliated cells
to identify and validate applicable biomarkers. We conclude that the gene expression profile of
exfoliated cervical cells partially represents that of tissue and is complex enough to provide
potential differentiation between disease and non-disease.
Background
Early cancer detection requires noninvasive sampling is
for general screening populations. Exfoliated cervical cells
have been used for cytologic screening of cervical cancer.
These accessible cells could also be ideal for molecular
screening based on gene expression if their mRNA can be
isolated and is representative of the expression profile of
the underlying tissue. We have previously shown that sat-
isfactory RNA can be isolated from pap smear material in
amounts sufficient for microarray analysis [1]. However
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since exfoliated cells are keratinized and terminally differ-
entiated, it remains to be demonstrated that they have an
active mRNA profile that adequately represents the molec-
ular signature of cervical tissue. While one group reported
success using exfoliated oral cells as a source of gene
expression biomarkers [2], others have not obtained satis-
factory results [3].
This study addresses the representation of gene expression
profiles in exfoliated cells and full thickness epithelium.
To further explore the possibility of using exfoliated cells
for molecular screening, we compared the gene expression
in samples with cervical intraepithelial neoplasia grade 3
(CIN3) to those without or only low grade lesions (CIN0,
CIN1).
Results
Gene expression profiles in cervical exfoliated cells and 
tissue
The MWG A, B and C human 30 k arrays include probes
evaluating 25,353 different genes of the transcribed
human genome. Of these genes, 14,544 (57%) were
detected in uterine cervix tissue and 10,158 (40%) in exfo-
liated cells (Figure 1). Of those detected in tissue, 7,320
(50.3%) were also detected in exfoliated cells. Genes
detected in each sample type grouped into the same major
GO categories in the same order of abundance (Figure 2),
although the numbers in each category were on average
20% less in exfoliated cells (range 4.4 – 27.3%). The
exception is the GO category, regulation of gene expres-
sion, epigenetics, in which the few genes that were
detected were only found in exfoliated cells.
EASE analysis of the 7,224 genes detected only in cervical
tissue found the biologic themes of structural cell compo-
nents, ribosomal function and structure, ion transport
and regulation to be enriched relative to their representa-
tion on the arrays (Table 1). Biologic themes enriched in
genes detected only in exfoliated cells were mainly differ-
entiation processes like neurogenesis, morphogenesis,
oncogenesis, organogenesis and development (Table 2).
Gene expression comparison of CIN3 samples with CIN0 
and CIN1 controls
Of the 5461 genes on the A arrays that were included in
this analysis, the average expression of 95 were at least 2-
fold greater whereas 10 were at least 2-fold lower in CIN3
compared to CIN 0/CIN 1. Based on CV, the CIN 3 class
showed more heterogeneity than the CIN 0 class (Figure
3) or the combined CIN 0/CIN 1 controls (data not
shown).
The univariate parametric p-values of the 20 most signifi-
cant genes that discriminate between the CIN3 and the
CIN 0/CIN 1 groups selected in the BRB Array Tools two-
sample T-test ranged between 0.00077 – 0.0067316.
None had a false discovery rate (FDR) of less than 10%.
The GO class comparison yielded 11 categories significant
at the nominal 0.005 level of permutation tests. These
were helicase activity, replication fork, DNA-directed
DNA polymerase activity, regulation of viral life cycle, per-
oxidase activity, DNA replication and endoplasmatic
reticulum membrane, or a closely related subcategory
(Table 3).
SAM yielded a trimmed list of 14 genes with a median
FDR of 35.7. Nine of these genes were also in the top list
generated with BRB Tools. Among the first 21 genes that
Focus identified as agreeing best with the hypothesized
pattern change, 12 were seen in BRB Array Tools top list
and 9 by SAM. Table 4 shows the six genes identified by
all three methods. All were upregulated in CIN3 by an
average fold change of 2.3 (2.0 – 3.3).
Discussion
Exfoliated cells from normal squamous epithelium are
derived from the terminally differentiated superficial lay-
ers and may have a more restricted representation of the
underlying tissue than those derived from a neoplastic
epithelium where differentiation is reduced or lost com-
pletely. Therefore results from the normal samples should
provide a conservative estimate of the degree of similari-
ties between cells and tissue. Grouping the detected genes
by broad ontology categories, the cervical tissue and cervi-
cal exfoliated samples showed a similar distribution, how-
ever exfoliated cells had fewer numbers of genes in each
category. The genes in common between tissue and exfo-
Number of genes expressed above cutoff in cervical tissue  and exfoliated cells Figure 1
Number of genes expressed above cutoff in cervical tissue 
and exfoliated cells.
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liated cell profiles represented 50% of the total genes
detected in tissue and 72% of the total detected in the
cells. Therefore, while much of the tissue gene profile is
included in the exfoliated cells, this representation is only
partial.
The 7224 genes that were not detected in exfoliated cells
could be expected to be involved in proliferation of the
basal epithelium. Even though the GOs of these genes did
not indicate a direct involvement of these genes in cell
division they did include basic components of cell struc-
ture and function. Interestingly, 6 of the 15 most signifi-
cant GOs were related to ribosome activity implying that
the ribosomal complex is not renewed after initial estab-
lishment in the basal cells.
It is interesting to note that 2,838 genes found in the exfo-
liated samples were not detected in the tissue. One expla-
nation may be the presence of inflammatory or other cells
such as endometrium that are not present in tissue. With
keratinocyte differentiation the profile becomes more
specialized as some genes are down regulated [4].
Therefore, another explanation may be that the restricted
RNA profile allows genes below the cutoff in tissue to
exceed the threshold for detection in exfoliated cells. This
is supported by the fact that average signal intensity
(sARM) of these genes was only one third of these
expressed in both specimens. The observation that the
GOs of these genes were relate to advanced differentiation
processes favors the latter explanation.
Since we used only one cervical tissue sample we
undoubtedly underestimated the true biologic variability
introduced by age, hormonal status and other environ-
mental factors. In addition, requiring detection in 6 of 7
exfoliated samples limits the transcriptome to those genes
GOs of biological processes in cervical exfoliated cells and full thickness epithelium Figure 2
GOs of biological processes in cervical exfoliated cells and full thickness epithelium. While expressed genes repre-
sent major categories in the same order, a proportion of each (4.4 to 27.3 %) is not present in exfoliated cells.
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that could reliably and reproducibly be detected by micro-
arrays. Additional study, including cervical tissues and
matched exfoliated samples from a spectrum of disease
states would be required to fully define the extent to
which tissue and exfoliated cell profiles overlap, nonethe-
less we conclude that exfoliated cells are worthy of further
investigation as a source of molecular markers for
screening.
To begin biomarker discovery we conducted a pilot micro-
array study of exfoliated cells from women with CIN3 to
those with no disease (CIN0) or CIN 1 to determine if dif-
ferential gene expression could be identified and evaluate
the degree of variation within disease groups to determine
the number of samples that would be required to stabilize
selection of differentially expressed genes. Not surpris-
ingly, the gene expression profiles of the two groups were
very similar. Based on cytology, less than 10% of the sam-
pled cells are neoplastic, so the dilution effect on abnor-
mal transcript profiles could be considerable. A "field
effect", that is extension of molecular changes to an area
larger than the histologically identifiable lesion, has been
Table 1: Biological themes enriched in genes detected only in tissue
Gene Category # of Genes EASE score†
Molecular Function Structural molecule activity 228 2.27E-07
Structural constituent of ribosome 78 4.21E-05
Extracellular matrix structural constituent 38 4.12E-04
Monovalent cation \:proton antiporter activity 7 3.90E-03
Sodium \:hydrogen antiporter activity 7 3.90E-03
Transcriptional repressor activity 18 1.31E-02
Voltage-gated sodium channel activity 9 1.58E-02
Cation \:cation antiporter activity 8 2.24E-02
Cellular Component Large ribosomal subunit 23 1.06E-03
Ribosome 90 2.20E-03
Cytosolic ribosome 24 6.14E-03
Cytosolic large ribosome subunit 16 9.87E-03
Cellular component unknown 160 1.22E-02
Collagen 15 1.36E-02
Ribonucleoprotein complex 127 1.52E-02
Biological process unknown 252 7.91E-04
†Cut-off <0.025
Table 2: Biological themes enriched in genes detected only in exfoliated cells
Gene Category # of Genes EASE score†
Biological process Neurogenesis 62 6.46E-04
Development 205 1.38E-03
Behavior 18 6.30E-03
Morphogenesis 122 1.04E-02
Regulation of cell adhesion 7 1.10E-02
Oncogenesis 14 1.38E-02
Cellular process 614 1.82E-02
Organogenesis 108 1.82E-02
* Chromatin remodeling complex 10 6.73E-03
Cell fraction 91 2.44E-02
** Protein tyrosine/serine/threonine phosphatase activity 91 3.23E-03
†Cut-off <0.025; *Cellular Component; **Molecular FunctionBMC Genomics 2005, 6:64 http://www.biomedcentral.com/1471-2164/6/64
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Plot of CV differences between CIN3 and CIN0 samples Figure 3
Plot of CV differences between CIN3 and CIN0 samples. CVs were calculated from normalized, log2 transformed 
sARM values for each gene. If variance in gene expression was random in both groups, approximately half the genes would be 
more variable in CIN 3 (positive) and half in CIN 0 (negative). The vertical dashed line divides the total number of genes in half 
(at gene 2730), the solid line marks where were the CVs are equal (at gene 3364). The increased number of genes with greater 
CV in the CIN 3 group indicates greater heterogeneity of expression profiles in this disease group compared with the control 
(CIN 0) group.
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demonstrated in other cancers including head and neck
[5], colon [6] and bladder [7]. There is some evidence that
this may occur in the cervix [8], but the extent to which
this occurs is not clear.
Using three different statistical approaches to identify dif-
ferentially expressed genes resulted in lists of candidate
genes with little overlap and relatively high estimates of
false discovery rates. These inconsistencies reflect the rela-
tively small differences between disease classes compared
to within-class variation. We intentionally represented a
wide range of age and race in this pilot so as not to over
simplify the within-class variation thereby maximizing
the specificity of the identified candidate biomarkers.
Interestingly, despite matching age and race between the
disease groups, the within-class variation was greater for
CIN 3 than for no disease or combined CIN 0 and CIN 1.
This suggests that cytologically identical CIN3 lesions may
represent different molecular pathways to oncogenesis.
There were 6 genes that were identified by all three analy-
sis methods. Given the central role of HPV in cervical car-
cinogenesis it is interesting that one of these, the
ubiquitin-conjugating enzyme E2 variant 1, participates
in the degradation of p53 through interaction with HPV
E6 protein [9]. Similarly, it is interesting to note an over-
representation of genes in the GO "viral life cycle" in
CIN3. While none of the others have been previously
implicated in cervical carcinogenesis this is not too
surprising, as their role may be restricted to premalignant
lesions or to host response.
Conclusion
The primary goal of this pilot study was to explore the
possibility of using exfoliated cells for genomic biomarker
discovery. We conclude that RNA from these cells can
indeed be applied to genomic studies. Exfoliated cells dis-
play an expression profile that reflects the tissue albeit
with limited complexity. In addition, the characteristic
expression differences between CIN 3 and control
samples (CIN 1 and no disease) are small and future stud-
ies need to be designed to address these factors.
Methods
Study population
The study population consisted of women enrolled into
an ongoing study of cervical neoplasia in high-risk urban
women [10]. Participants were recruited from non-preg-
nant, HIV-negative women, aged 18–69 years, attending
colposcopy clinics at urban public hospitals in Atlanta,
Table 3: GO categories with higher than expected numbers of genes differentially regulated in CIN3(p < 0.005).
GO category GO description LS Permut. p-value KS Permut. p-value
0004376 Helicase activity 0.00129 0.00718
0001724 RNA helicase activity 0.00196 0.01317
0030894 Replisome 0.00811 1e-04
0005657 Replication fork 0.01098 7e-04
0003887 DNA-directed DNA polymerase activity 0.01822 0.00253
0050792 Regulation of viral life cycle 0.03079 0.00364
0004601 Peroxidase activity 0.03864 0.00382
0016684 Oxidoreductase activity 0.03864 0.00382
0006260 DNA replication 0.06296 0.00403
0006270 DNA replication initiation 0.07700 0.00066
0004789 Endoplasmic reticulum membrane 0.09838 0.00409
Table 4: Genes with statistically significant upregulated expression in CIN3. Six genes were indicated by all three analysis methods 
(BRB Array-Tools, SAM, Focus). Fold changes are shown as calculated by SAM.
GenBank ID Gene Name Fold Change
NM_021988 ubiquitin-conjugating enzyme E2 variant 1 2.0
NM_018307 ras homolog gene family, member T1 2.1
NM_024719 growth hormone regulated TBC protein 1 2.3
NM_007083 nudix type motif 6 2.1
NM_022841 hypothetical protein FLJ12994 3.3
NM_016175 truncated calcium binding protein 2.0BMC Genomics 2005, 6:64 http://www.biomedcentral.com/1471-2164/6/64
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Georgia and Detroit, Michigan. Specimens used in this
study were from participants enrolled between December
2000 and December 2002. Cervical disease status was
determined based on the summary results of cytology,
colposcopy and biopsy examination. We selected 15
women with high grade lesions (CIN3) as cases and age (±
4 years) and race matched women without or with only
low grade lesions as controls (7 CIN0 and 8 CIN1).
Sample collection and RNA extraction
After visualization of the cervix, ecto- and endocervical
cells were collected using a CytoBroom (Cytyc Corpora-
tion, Malborough, MA) and dislodged into PreservCyt
collection media (Cytyc Corporation). If a cytology diag-
nosis was required, the collection device was used to pre-
pare a conventional Pap smear and then placed into the
PreservCyt collection media. Samples were transported to
the laboratory at ambient temperature and stored at 4°C
until processed. Within two weeks of sample collection,
total nucleic acids (TNA) were extracted from 14 ml of
each 20 ml PreservCyt sample using modifications of the
MasterPure Complete DNA and RNA Purification kit
(Epicentre, Madison, WI) as previously described (Habis
et al 2004). The TNA extract was resuspended in 50 µL TE
buffer with 50 units of RNasin (Promega Corporation,
Madison, WI) and stored at -70°C until use. Total RNA
derived from normal uterine cervix tissue (age 48,
unknown ethnicity) was purchased (Stratagene®, La Jolla,
CA). Quality of all samples was visually evaluated by gel
electrophoresis and quantitation was assessed by densito-
metric measurement (FluorChem® Digital Imaging Sys-
tem, Alpha Innotech, Inc., San Leandro, CA) of the
ribosomal bands, with comparison to a standard 28S and
18S control marker.
Microarray assays
We used MWG Human 30 k Arrays (A/ B/ C) (MWG Bio-
tech, Ebersberg, Germany). Each array was hybridized
with cDNA prepared from 500 ng total RNA. Conditions
for labeling and hybridization were as described else-
where [11]. Briefly, samples were pretreated with DNase I
and cDNA was prepared and labeled with biotin-11-dUTP
(Enzo, Farmingdale, NY) using SuperScript™ First-Strand
Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA)
with oligo dT and random primers. The automated Dis-
covery™ System (Ventana Medical Systems, Tucson, AZ)
was used to hybridize slides for 8 hours at 42°C, and
detect hybridization with anti-biotin Gold Resonance
Light Scattering (RLS) Particles (Invitrogen). Slides were
scanned with the GSD-501™ RLS scanner (Invitrogen) and
16-Bit Tiff images were subsequently quantified with
Array Vision™ Software 8.0 (Imaging Research, St Cather-
ines, ON, Canada). We used sARM values (artifact
removed density minus the background density) of each
feature for statistical analysis and a signal to noise ratio (S/
N = sARM, divided by the SD of the background density)
of 1.5 as the cut-off for detection of gene expression.
Comparison of gene expression in cervical exfoliated cells 
and uterine cervix tissue
We used the results of the 7 samples of exfoliated cells
from women with no abnormalities (CIN0) to character-
ize the profile of exfoliated cells and of the uterine cervix
tissue RNA assayed in duplicate to characterize the tissue
profile. A gene was included in the profile if detected in
>85% of the exfoliated samples (6 of 7) or in both repli-
cates of the tissue sample. We used the web based data-
base for annotation, visualization and integrated
discovery (DAVID) http://david.niaid.nih.gov/David/
[12] for functional annotation and ontology of the
detected genes, and the expression analysis systematic
explorer (EASE) for identification of enriched biological
themes within the gene lists as reflected by an EASE score
of < 0.025 [13].
Differential gene expression in CIN0/CIN1 and CIN3 
samples
Expression data were derived from the results of all 30
exfoliated samples hybridized to MWG A arrays. Features
were restricted to those with a S/N above 1.5 detected in
at least 12 of the 15 samples (80%) of either class (CIN0/
CIN1 or CIN3). 5461 genes that passed this filter were
subjected to further statistical analysis.
We calculated the mean and coefficient of variation (CV)
of the log2 transformed median centered sARM for each
gene within the CIN 3, CIN 0 and CIN 1/CIN 0 groups.
We used the CV in expression of each gene as a measure of
homogeneity. For each gene we calculated the difference
between the CV of the CIN 3 group minus that of the
other groups and plotted these values in descending order
to visualize discrepancies in the variation of genes expres-
sion between the classes.
To identify expression differences between the two groups
we used the following three different microarray-adapted
statistical software packages:
(1) BRB Array Tools 3.2 http://linus.nci.nih.gov/BRB-
ArrayTools: Log2 transformed sARM values were normal-
ized over the median of each array and subjected to a two-
sample T-test with a random variance model and 1000
permutations. We considered the top 20 genes with the
lowest univariate parametric p-values as differentially
expressed. Multivariate permutation tests were applied to
estimate the proportion of false discoveries in the discov-
ery list. The indicated genes were assigned to gene ontol-
ogy (GO) categories. Additionally, all GO categories that
included at least 5 genes represented on the microarray
were analyzed to identify biological themes overrepre-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Genomics 2005, 6:64 http://www.biomedcentral.com/1471-2164/6/64
Page 8 of 8
(page number not for citation purposes)
sented in genes differentially expressed. A GO category
was selected if its corresponding LS or KS permutation p-
value was below the threshold of 0.005 [14].
(2) Significant analysis of microarrays (SAM) 1.21 http://
www-stat.stanford.edu/~tibs/SAM/: sARM values were
log2 transformed and centered to the median of each
array. Normalized data were analyzed in an unpaired,
two-class model with gene specific t-tests and 200
permutations to estimate false discovery rate (FDR) from
multiple testing. Genes were scored based on change in
expression relative to the standard deviation of the
repeated measurements in order to identify those with dif-
ferential expression [15].
(3) Focus 5.1 http://microarray.genetics.ucla.edu/focus/:
Raw sARM data were normalized to a modified Z-transfor-
mation and tested for the hypothesis, gene expression in
CIN3 samples is upregulated over controls. The applied
contrast coefficient of 1.0 scored genes directly according
to the average intensity difference between the two classes
[16]. Genes agreeing best with the hypothesized pattern
change were trimmed to a list of 20 with the highest inter-
est scores and at least a 2-fold change.
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